{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:32:26Z","timestamp":1788503546474,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.vaccine.2009.02.047","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T05:35:12Z","timestamp":1235540112000},"page":"2447-2452","source":"Crossref","is-referenced-by-count":53,"title":["On the use of hemagglutination-inhibition for influenza surveillance: Surveillance data are predictive of influenza vaccine effectiveness"],"prefix":"10.1016","volume":"27","author":[{"given":"Wilfred","family":"Ndifon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dushoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.02.047_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/aje\/kwj024","article-title":"Mortality due to influenza in the United States \u2013 an annualized regression approach using multiple-cause mortality data","volume":"163","author":"Dushoff","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.02.047_bib2","unstructured":"World Health Organization. Influenza Factsheet. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/ [cited September 15, 2007]."},{"key":"10.1016\/j.vaccine.2009.02.047_bib3","series-title":"Influenza virology: current topics","article-title":"Epidemiology and control of human and animal influenza","author":"Subbarao","year":"2006"},{"key":"10.1016\/j.vaccine.2009.02.047_bib4","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1001\/jama.297.18.2025","article-title":"The next influenza pandemic \u2013 can it be predicted?","volume":"297","author":"Taubenberger","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.02.047_bib5","series-title":"Firepower in the lab: automation in the fight against infectious diseases and bioterrorism","first-page":"47","article-title":"Expanding the worldwide influenza surveillance system and improving the selection of strains for vaccines","author":"Cox","year":"2001"},{"key":"10.1016\/j.vaccine.2009.02.047_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3201\/eid1204.051198","article-title":"Human influenza surveillance: the demand to expand","volume":"12","author":"Layne","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.047_bib7","unstructured":"Webster R, Cox N, Stohr K. WHO Manual on Animal Influenza Diagnosis and Surveillance. WHO\/CDS\/CSR\/NCS\/2002.5 Rev.1, 2002."},{"key":"10.1016\/j.vaccine.2009.02.047_bib8","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1002\/aic.10718","article-title":"Entropy disease and new opportunities for chemical engineering research","volume":"51","author":"Deem","year":"2005","journal-title":"AIChE J"},{"key":"10.1016\/j.vaccine.2009.02.047_bib9","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/j.vaccine.2006.01.010","article-title":"Quantifying influenza vaccine efficacy and antigenic distance","volume":"24","author":"Gupta","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.047_bib10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.vaccine.2004.08.028","article-title":"Epitope analysis for influenza vaccine design","volume":"23","author":"Munoz","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.047_bib11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jama.284.13.1655","article-title":"Effectiveness and cost-benefit of influenza vaccination of healthy working adults \u2013 a randomized controlled trial","volume":"284","author":"Bridges","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.02.047_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11096-007-9137-8","article-title":"The evaluation of free influenza vaccination in health care workers in a medical center in Taiwan","volume":"30","author":"Chan","year":"2008","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.vaccine.2009.02.047_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1126\/science.94.2427.22","article-title":"The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus","volume":"94","author":"Hirst","year":"1941","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.02.047_bib14","first-page":"476","article-title":"A critique of serologic methods for the study of influenza viruses","volume":"4","author":"Salk","year":"1951","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2009.02.047_bib15","unstructured":"Centers for Disease Control and Prevention. Information for the vaccines and related biological products advisory committee, CBER FDA WHO Collaborating Center for surveillance epidemiology and control of influenza; 2003."},{"key":"10.1016\/j.vaccine.2009.02.047_bib16","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3201\/eid1008.040107","article-title":"Predicting antigenic variants of influenza A\/H3N2 viruses","volume":"10","author":"Lee","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.047_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1084\/jem.92.5.441","article-title":"Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum","volume":"92","author":"Archetti","year":"1950","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.02.047_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/oxfordjournals.epirev.a017990","article-title":"Design and interpretation of vaccine field studies","volume":"21","author":"Halloran","year":"1999","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2009.02.047_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0167-9473(99)00100-0","article-title":"Estimating the ratio of two Poisson rates","volume":"34","author":"Prince","year":"2000","journal-title":"Comp Stat Dat Anal"},{"key":"10.1016\/j.vaccine.2009.02.047_bib20","unstructured":"Centers for Disease Control and Prevention. Flu vaccine effectiveness: questions and answers for health professionals. Available at: http:\/\/www.cdc.gov\/flu\/professionals\/vaccination\/effectivenessqa.htm 2006 [cited September 15, 2007]."},{"key":"10.1016\/j.vaccine.2009.02.047_bib21","doi-asserted-by":"crossref","first-page":"12182","DOI":"10.1128\/JVI.75.24.12182-12187.2001","article-title":"Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals","volume":"75","author":"Goronzy","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.02.047_bib22","first-page":"543","article-title":"An evaluation of influenza immunization: influence of route of administration and vaccine strain","volume":"41","author":"Waldman","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.02.047_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/infdis\/126.3.242","article-title":"Influenza immunization: field trial on a university campus","volume":"126","author":"Waldman","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.047_bib24","unstructured":"World Health Organization Weekly Epidemiological Record 1975;50:45\u201352."},{"key":"10.1016\/j.vaccine.2009.02.047_bib25","unstructured":"World Health Organization Weekly Epidemiological Record 1974;49:41\u20138."},{"key":"10.1016\/j.vaccine.2009.02.047_bib26","unstructured":"World Health Organization Weekly Epidemiological Record 1972;47:73\u201384."},{"key":"10.1016\/j.vaccine.2009.02.047_bib27","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1128\/JVI.02458-06","article-title":"Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe","volume":"81","author":"de Jong","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.02.047_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S0022172400025936","article-title":"Vaccination against influenza: a five-year study in the post office","volume":"83","author":"Smith","year":"1979","journal-title":"J Hyg"},{"key":"10.1016\/j.vaccine.2009.02.047_bib29","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination","volume":"96","author":"Smith","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.02.047_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JVI.48.1.52-60.1983","article-title":"Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites","volume":"48","author":"Both","year":"1983","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.02.047_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/IAI.27.2.397-404.1980","article-title":"Serology and cross-reactions among the H3 antigens of influenza viruses","volume":"27","author":"Underwood","year":"1980","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.02.047_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0264-410X(98)90040-8","article-title":"Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population","volume":"2","author":"Tannock","year":"1984","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.047_bib33","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1098\/rstb.2001.0999","article-title":"The evolution of human influenza viruses","volume":"356","author":"Hay","year":"2001","journal-title":"Phil Trans R Soc Lond"},{"key":"10.1016\/j.vaccine.2009.02.047_bib34","unstructured":"World Health Organization Weekly Epidemiological Record 1988;63:57\u20139."},{"key":"10.1016\/j.vaccine.2009.02.047_bib35","unstructured":"World Health Organization Weekly Epidemiological Record 1986;61:61\u20138."},{"key":"10.1016\/j.vaccine.2009.02.047_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a114809","article-title":"Efficacy of sequential annual vaccination with inactivated influenza virus vaccine","volume":"127","author":"Keitel","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.02.047_bib37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0264-410X(97)00003-0","article-title":"Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period","volume":"15","author":"Keitel","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.047_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02595754","article-title":"Do hospital employees benefit from the influenza vaccine?","volume":"3","author":"Weingarten","year":"1988","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2009.02.047_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/infdis\/169.1.68","article-title":"A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease","volume":"169","author":"Edwards","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.047_bib40","unstructured":"Morbidity and Mortality Weekly Report 1990;39:293\u201396."},{"key":"10.1016\/j.vaccine.2009.02.047_bib41","doi-asserted-by":"crossref","unstructured":"World Health Organization Weekly Epidemiological Record 1990;65:53\u201360.","DOI":"10.1111\/j.1746-1561.1990.tb05955.x"},{"key":"10.1016\/j.vaccine.2009.02.047_bib42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00043764-199705000-00006","article-title":"Cost-effectiveness of the influenza vaccine in a healthy, working-age population","volume":"39","author":"Campbell","year":"1997","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.vaccine.2009.02.047_bib43","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/infdis\/171.6.1595","article-title":"Influenza A virus vaccine containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults","volume":"171","author":"Powers","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.047_bib44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM199510053331401","article-title":"The effectiveness of vaccination against influenza in healthy, working adults","volume":"333","author":"Nichol","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.02.047_bib45","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1086\/513934","article-title":"Influenza vaccine efficacy in young, healthy adults","volume":"26","author":"Grotto","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.047_bib46","unstructured":"Morbidity and Mortality Weekly Report 1998;47:196\u2013200."},{"key":"10.1016\/j.vaccine.2009.02.047_bib47","unstructured":"World Health Organization Weekly Epidemiological Record 1998;73:56\u201363."},{"key":"10.1016\/j.vaccine.2009.02.047_bib48","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s007050170025","article-title":"Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in Spain from 1996 to 2000","volume":"146","author":"Coiras","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2009.02.047_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/occmed\/52.5.281","article-title":"Reduced efficiency of influenza vaccine in prevention of influenza-like illness in working adults: a 7 month prospective survey in EDF Gaz de France employees, in Rhone-Alpes 1996\u20131997","volume":"52","author":"Millot","year":"2002","journal-title":"Occup Med Oxford"},{"key":"10.1016\/j.vaccine.2009.02.047_bib50","first-page":"876","article-title":"Impact of influenza vaccination on civilian aircrew illness and absenteeism","volume":"73","author":"Mixeu","year":"2002","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.vaccine.2009.02.047_bib51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/502146","article-title":"Use of, effectiveness of, attitudes regarding influenza vaccine among house staff","volume":"24","author":"Lester","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2009.02.047_bib52","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1016\/S0264-410X(03)00508-5","article-title":"A prospective, internet-based study of the effectiveness and safety of influenza vaccination in the 2002 influenza season","volume":"21","author":"Kawai","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.047_bib53","unstructured":"World Health Organization Weekly Epidemiological Record 2003;78:57\u201364."},{"key":"10.1016\/j.vaccine.2009.02.047_bib54","unstructured":"Morbidity and Mortality Weekly Report 2004;53:8\u201311."},{"key":"10.1016\/j.vaccine.2009.02.047_bib55","unstructured":"Morbidity and Mortality Weekly Report 2004;53:547\u201352."},{"key":"10.1016\/j.vaccine.2009.02.047_bib56","unstructured":"Centers for Disease Control and Prevention. Information for the vaccines and related biological products advisory committee, CBER FDA WHO Collaborating Center for surveillance epidemiology and control of influenza; 2005."},{"key":"10.1016\/j.vaccine.2009.02.047_bib57","unstructured":"Morbidity and Mortality Weekly Report 2005;54:631\u201334."},{"key":"10.1016\/j.vaccine.2009.02.047_bib58","unstructured":"Morbidity and Mortality Weekly Report 2007;56:1001\u20134."},{"key":"10.1016\/j.vaccine.2009.02.047_bib59","unstructured":"Centers for Disease Control and Prevention: fluview: 2007\u20132008 Influenza Season Week 9 ending March 1 2008. Available at: http:\/\/www.cdc.gov\/flu\/weekly\/."},{"key":"10.1016\/j.vaccine.2009.02.047_bib60","unstructured":"World Health Organization. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use in human vaccines. Available at: http:\/\/www.who.int\/csr\/disease\/avian_influenza\/guidelines\/200809_H5VaccineVirusUpdate.pdf [cited September 2008]."},{"key":"10.1016\/j.vaccine.2009.02.047_bib61","unstructured":"The Influenza Genome Sequencing Project, http:\/\/www3.niaid.nih.gov\/research\/resources\/mscs\/Influenza\/."},{"key":"10.1016\/j.vaccine.2009.02.047_bib62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.02.047_bib63","first-page":"214","article-title":"The effect of vaccine on a closed epidemic of Hong Kong influenza","volume":"44","author":"Eddy","year":"1970","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2009.02.047_bib64","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.211.10.1672","article-title":"Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines","volume":"211","author":"Mogabgab","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.02.047_bib65","first-page":"419","article-title":"Properties of the Hong Kong influenza virus 2 Antigenic relationship of the Hong Kong virus haemagglutinin to that of other human influenza A viruses","volume":"41","author":"Dowdle","year":"1969","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T23:58:02Z","timestamp":1589587082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":65,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0264410X09003107"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}